In the phase 1b/2a study, once-weekly subcutaneous amycretin at a dose of 60 mg resulted in 24.3% weight loss at week 36, with a tolerability profile consistent with that of GLP-1 and AMYR agonists
Monthly during use: Self-examine all moles using the ABCDE criteria: - A symmetry: One half does not match the other - B order: Edges are irregular, ragged, or blurred - C olor: Uneven color with shades of brown, black, red, white, or blue - D iameter: Larger than 6 mm (the size of a pencil eraser) - E volving: Any change in size, shape, color, elevation, or any new symptom (bleeding, itching, crusting) 3
excess glutamate can theoretically lower the seizure threshold or trigger manic episodes in susceptible individuals
The patch is intended for topical use on clean, dry skin and is worn for the time specified in the instructions
J Endocr Soc
Giving them more frequently than the established schedule is a form of over-treatment that is not supported by evidence and can strain healthcare resources (nurses time, clinic space, and medication supplies)